文献速递前列腺癌

中危前列腺癌PSMA PET阴性可否免除盆腔淋巴结清扫:系统综述与诊断性荟萃分析

Can pelvic lymph node dissection be spared in intermediate-risk prostate cancer patients with negative PSMA PET scan? A systematic review and diagnostic meta-analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2026-03-19

汇总敏感度为49%(95%CI 27-72%),特异度为95%(95%CI 93-97%),阴性预测值为95%(95%CI 91-98%)。结论提示PSMA PET阴性者或可免除盆腔淋巴结清扫,但敏感度中等及漏诊微转移风险需谨慎决策。

要点

  • 中危前列腺癌PSMA PET阴性者汇总阴性预测值达95%,或可免除盆腔淋巴结清扫。
  • PSMA PET/CT检测淋巴结侵犯汇总敏感度仅49%,存在漏诊微转移病灶的风险。
  • 该策略需谨慎应用并共同决策,尚待大规模前瞻性验证及临床结局随访支持。

核心结论

  • 当前诊断证据的荟萃分析提示,中危前列腺癌患者PSMA PET扫描阴性时,根治性前列腺切除术中或可免除盆腔淋巴结清扫。
  • PSMA PET敏感度中等及漏诊微转移疾病的相关风险,强调需谨慎应用并共同决策。

研究设计与样本

  • 以盆腔淋巴结清扫的组织病理学和临床随访作为参考标准。
  • 基于患者的敏感度和特异度采用双变量随机效应模型汇总,阴性预测值采用DerSimonian-Laird模型汇总。

主要发现

  • PSMA PET/CT检测淋巴结侵犯的敏感度范围为0%至100%,特异度范围为87%至99%。
  • 汇总敏感度为49%(95%CI 27-72%),汇总特异度为95%(95%CI 93-97%)。
  • PSMA PET/CT检测淋巴结侵犯的阴性预测值范围为74%至100%,汇总阴性预测值为95%(95%CI 91-98%)。

临床怎么用

  • 中危前列腺癌患者若PSMA PET扫描阴性,可在根治性前列腺切除术时考虑免除盆腔淋巴结清扫。
  • 应用该策略时需结合PSMA PET敏感度中等及漏诊微转移的风险,进行谨慎评估与共同决策。

局限性

  • 纳入研究总体方法学质量为中等。
  • PSMA PET敏感度中等,存在漏诊微转移疾病的相关风险。
  • 尚需大规模前瞻性验证研究及关注患者临床结局的随访结果提供更强支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to meta-analyze published data on the diagnostic performance of PSMA PET/CT in detecting lymph node invasion (LNI) in intermediate-risk prostate cancer (PCa) patients, and to discuss whether pelvic lymph node dissection (PLND) can be spared in patients with negative PSMA PET scan. PATIENTS AND METHODS: The PubMed and Embase databases were searched through November 2025 to identify relevant articles. Methodological quality of each study was assessed. Patient-based sensitivity and specificity were pooled using the bivariate random-effects model. Patient-based negative predictive value (NPV) was pooled using the DerSimonian-Laird model. Histopathology from PLND and clinical follow-up served as the reference standard. RESULTS: Twelve eligible studies, comprising a total of 1619 patients with intermediate-risk PCa, were included. Overall, the studies were of moderate methodological quality. The sensitivity and specificity of PSMA PET/CT for the detection of LNI ranged from 0% to 100% and from 87% to 99%, respectively, with pooled estimates of 49% [95% confidence interval (CI) 27-72%] and 95% (95% CI 93-97%), respectively. The NPV of PSMA PET/CT for the detection of LNI ranged from 74% to 100%, with pooled estimates of 95% (95% CI 91-98%). CONCLUSION: This meta-analysis of current diagnostic evidence suggests that intermediate-risk PCa patients with negative PSMA PET scan may omit PLND at the time of radical prostatectomy. However, the moderate sensitivity of PSMA PET and the associated risk of missing micrometastatic disease underscore the need for cautious application and shared decision-making. Further large-scale prospective validation studies and future follow-up results focusing on the clinical outcomes of these patients will lend stronger support to this approach.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Wan QC, Min KY, Wei L, et al. Can pelvic lymph node dissection be spared in intermediate-risk prostate cancer patients with negative PSMA PET scan? A systematic review and diagnostic meta-analysis. Prostate Cancer Prostatic Dis. 2026. PMID: 41857380. doi:10.1038/s41391-026-01103-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。